已收盤 10-03 16:00:00 美东时间
+2.490
+3.36%
Innospec Inc. announced the release of its third quarter 2025 earnings on November 4, 2025, after market close. A conference call hosted by Patrick S. Williams and Ian Cleminson will follow on November 5, 2025, at 10:00 a.m. ET. Public participation requires advance registration via the provided link, which offers dial-in details and a Personal PIN. An audio webcast will also stream live on the company’s website, with a replay available for 30 da...
10-01 20:45
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从34美元升至35美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.5美元升至7.75美元
09-23 09:52
<p>Inspira Technologies will showcase its HYLA blood sensor at the U.S. ELSO Annual Conference, highlighting its 97.35% accuracy compared to standard blood gas analyzers. The event serves as a platform to engage with global clinicians and advance commercialization discussions. The company will also demonstrate its FDA-cleared ART100 system, underscoring its commitment to innovative life-support solutions.</p>
09-18 12:00
InspireMD appoints Dan Dearen to its Board of Directors, bringing nearly 40 years of leadership experience in the medical device sector. Dearen's expertise in guiding MedTech companies through critical financial milestones and delivering shareholder value aligns with InspireMD's mission to advance its CGuard® Prime carotid stent system and execute its value-creation strategy. Dearen's addition is timed with the U.S. commercial launch of CGuard Pr...
09-17 12:00
中国质量新闻网讯 近日,山东省市场监督管理局公布2025年电动汽车充电桩产品质量省级监督抽查结果。2025年第2批产品质量省级监督抽查共抽查生产环节电动汽车充电...
09-16 14:10
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.Mont-Saint-Guibert, Belgium – September 15, 2025, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) and Nyxoah,
09-16 04:11
BGSF Inc. (NYSE: BGSF) announces special cash dividend of $2.00 per share, following sale of Professional Division to return value to investors.
09-12 22:09
Inspira Technologies announced that its HYLA blood sensor achieved 97.35% accuracy in performance testing, supporting upcoming FDA submission. The device features continuous, non-invasive monitoring and is versatile for various medical procedures. HYLA is designed to integrate with existing devices, targeting global markets with a recurring revenue model. The Company highlighted its potential to revolutionize real-time blood monitoring in critica...
09-11 13:30
Inspire Medical Systems (NYSE:INSP) underwent analysis by 14 analysts in the la...
09-03 02:01
Inspire Medical Systems (NYSE:INSP) is reaffirming updated 2025 financial guidance it made earlier this month following its Q2 results. At that time, the maker of a sleep apnea treatment implant signi...
08-27 05:03